2.3. Venetoclax Re-Sensitized Drug-Selected Wild Type ABCG2-Overexpressing MDR Cancer Cells without Affecting Drug-Selected Mutated ABCG2-Overexpressing and ABCB1-Overexpressing Cancer Cells. This evidence concerns the gene ABCG2 and cancer.